These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1757211)

  • 1. A role for a non-androgenic anovulant in the management of hirsutism.
    McKenna TJ; Cunningham SK
    Ir J Med Sci; 1991 Jul; 160(7):194-6. PubMed ID: 1757211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open study of Triphasil and Diane 50 in the treatment of acne.
    Wishart JM
    Australas J Dermatol; 1991; 32(1):51-4. PubMed ID: 1834045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
    Sahin Y; Dilber S; Keleştimur F
    Fertil Steril; 2001 Mar; 75(3):496-500. PubMed ID: 11239530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
    Frölich M; Lachinsky N; Moolenaar AJ
    Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on clinical signs of androgenization, hormone profile and ovarian size in patients with polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Balint-Perić L; Puzigaća Z
    Gynecol Endocrinol; 1989 Dec; 3(4):269-80. PubMed ID: 2516704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen levels during cyproterone acetate and ethinyl oestradiol treatment of hirsutism.
    Rubens R
    Clin Endocrinol (Oxf); 1984 Mar; 20(3):313-25. PubMed ID: 6233049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of severe hirsutism resulting from hyperandrogenism with the reverse sequential cyproterone acetate regimen.
    Garner PR; Poznanski N
    J Reprod Med; 1984 Apr; 29(4):232-6. PubMed ID: 6232380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyproterone acetate as initial treatment and maintenance therapy for hirsutism.
    Holdaway IM; Croxson MS; Ibbertson HK; Sheehan A; Knox B; France J
    Acta Endocrinol (Copenh); 1985 Aug; 109(4):522-9. PubMed ID: 2930987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism.
    Sahin Y; Bayram F; Keleştimur F; Müderris I
    J Endocrinol Invest; 1998 Jun; 21(6):348-52. PubMed ID: 9699125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission.
    Carmina E; Lobo RA
    Hum Reprod; 1997 Apr; 12(4):663-6. PubMed ID: 9159420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for hirsutism (excluding laser and photoepilation therapy alone).
    van Zuuren EJ; Fedorowicz Z; Carter B; Pandis N
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010334. PubMed ID: 25918921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
    Barth JH; Cherry CA; Wojnarowska F; Dawber RP
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):5-10. PubMed ID: 1832346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
    Spona J; Huber J; Schmidt JB
    Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficiency of anti-androgenic regimens consisting of spironolactone, Diane 35, and cyproterone acetate in hirsutism.
    Sert M; Tetiker T; Kirim S
    Acta Med Okayama; 2003 Apr; 57(2):73-6. PubMed ID: 12866746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hair growth and androgen responses in hirsute women treated with continuous cyproterone acetate and cyclical ethinyl oestradiol.
    Jones DB; Ibraham I; Edwards CR
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):497-501. PubMed ID: 2962412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyproterone acetate on rate of hair growth in hirsute females.
    Jones KR; Katz M; Keyzer C; Gordon W
    Br J Dermatol; 1981 Dec; 105(6):685-92. PubMed ID: 6459114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ovarian suppression with Diane 35/50].
    Erdmann D; Schindler EM; Schindler AE
    Geburtshilfe Frauenheilkd; 1994 Nov; 54(11):627-33. PubMed ID: 8719015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monthly cyproterone acetate in the treatment of hirsute women: clinical and laboratory effects.
    Marcondes JA; Wajchenberg BL; Abujamra AC; Luthold WW; Samojlik E; Kirschner MA
    Fertil Steril; 1990 Jan; 53(1):40-4. PubMed ID: 2136835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Diane 35 and Diane 35 plus spironolactone in the treatment of hirsutism.
    Keleştimur F; Sahin Y
    Fertil Steril; 1998 Jan; 69(1):66-9. PubMed ID: 9457935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an oral contraceptive containing cyproterone acetate (Diane-35) on the symptoms, hormone profile, and ovarian volume of hirsute women with polycystic ovarian syndrome.
    Prelević GM; Puzigaća Z; Balint-Perić LA
    Ann N Y Acad Sci; 1993 May; 687():255-62. PubMed ID: 8323181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.